LOADING
Comparing NVIDIA Corporation (NVDA) and Thermo Fisher Scientific (TMO) across the Technology and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | NVDA | TMO |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $5.01T | $213.3B |
| P/E Ratio | 31.7 | 30.9 |
| Forward P/E | 22.9 | 22.9 |
| PEG Ratio | 0.55 | 1.87 |
| EPS | $6.52 | $18.61 |
| Revenue Growth (YoY) | 85.2% | 10.5% |
| Profit Margin | 63.0% | 15.0% |
| Return on Equity | 114.3% | 13.5% |
| Dividend Yield | 0.02% | 0.31% |
| Beta | 2.21 | 0.85 |
| 52-Week High | $236.26 | $642.71 |
| 52-Week Low | $163.85 | $434.83 |
| Volume | -- | -- |
NVIDIA Corporation is the larger company by market capitalization. Thermo Fisher Scientific trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Thermo Fisher Scientific offers a higher dividend yield for income investors. NVIDIA Corporation has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.